US Patent 7608592 HCV inhibitors
Patent 7608592 was granted and assigned to Virobay on October, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+359 characters)
Article
Patent abstract
The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07608592 HCV inhibitors US Patent 7608592 HCV inhibitors
Infobox
Patent Number
0760859200
Patent Number
760859200
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076085920
Date of Patent
October 27, 2009
0Patent Application Number
114783370
Date Filed
June 28, 2006
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076085920
Date of Patent
October 27, 2009
0Patent Application Number
114783370
Date Filed
June 28, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07608592 HCV inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07608592
Date of patent
October 27, 2009
Patent application number
11478337
Date Filed
June 28, 2006
Patent primary examiner
Find more entities like US Patent 7608592 HCV inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.